Amersham Biosciences Launches IN Cell Analyzer 3000; High-Throughput Imaging System Enables...

Business Editors & Health/Medical Writers

BIOWIRE2K

PISCATAWAY, N.J.--(BUSINESS WIRE)--Sept. 23, 2002

Amersham Biosciences, the life sciences business of Amersham plc (LSE: NYSE: OSE: AHM), announced the commercial availability of IN Cell Analyzer 3000, a sub cellular

IN Cell Analyzer 3000 is an extremely sensitive imaging tool that uses a laser-based, confocal imaging system with three high-speed CCD cameras to enable high-throughput and high-content testing of drug compounds. In addition to state of the art instrumentation, a wide range of image analysis algorithms are available. These algorithms offer real-time analysis capabilities and are extremely flexible. By altering the user definable parameters, each algorithm is capable of automatically analyzing a wide range of cellular changes. The availability of this system offers scientists working in lead discovery and target validation access to the most advanced imaging and analytical technology on the market today.

IN Cell Analyzer 3000 is capable of generating and analyzing over 35,000 three-color cellular images in less than 24 hours. The instrument is designed and validated for continuous operation and is therefore perfectly suited for a screening environment. The ability to generate data and knowledge in a cellular environment offers pharmaceutical companies the potential to discover and develop new drugs more quickly and cost-effectively.

"IN Cell Analyzer 3000 gives scientists working in lead discovery unprecedented power for drug testing, The ability to observe directly, in real time, a drug compound entering a cell, and the biological changes that occur in response to drug activity, is dramatic testimony to the exquisite sensitivity and unsurpassed analytical power of the IN Cell Analyzer 3000," said John Sutton, Vice President, Product Management, Bioassays, for Amersham Biosciences.

Amersham Biosciences also recently announced plans to introduce IN Cell Analyzer 1000, a medium-throughput, highly flexible sub cellular analysis system that complements IN Cell Analyzer 3000. The company is co-developing this system with Imaging Research Inc. (St. Catharines, Ontario, Canada).

Amersham Biosciences, the life sciences business of Amersham plc (LSE: NYSE: OSE: AHM), is a world leader in developing and providing integrated systems and solutions for disease research, drug development and manufacture. Our systems are used to uncover the function of genes and proteins, for the discovery and development of drugs and for the manufacture of biopharmaceuticals. The customers for Amersham Biosciences' products and technology are pharmaceutical and biotechnology companies and research and academic institutions, principally in North America, Europe, Latin America and Asia. For more information please visit our web site at www.amershambiosciences.com.

Amersham Biosciences - enabling molecular medicine